FLT3-mutated Acute Myeloid Leukemia

Explore clinical trials studying FLT3-mutated Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

FLT3-mutated Acute Myeloid Leukemia trial results

Completed

NCT02310321

Conditions: Acute Myeloid Leukemia, FLT3-mutated Acute Myeloid Leukemia, Hematologic Diseases, +6 more
Locations: Site JP81037 Anjo, Aichi-ken, Japan

Site JP00003 Nagoya, Aichi-ken, Japan

Site JP81003 Nagoya, Aichi-ken, Japan

Site JP81027 Nagoya, Aichi-ken, Japan

View all 55 locations

Active, Not Recruiting

NCT03591510

Conditions: FLT3-mutated Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Novartis Investigative Site Prague, Czechia

Novartis Investigative Site Berlin, Germany

Novartis Investigative Site Essen, Germany

Novartis Investigative Site Pavia, PV, Italy

View all 15 locations

Active, Not Recruiting

NCT05520567

Conditions: Acute Myeloid Leukemia (AML), FLT3-mutated Acute Myeloid Leukemia, Hematologic Diseases, +6 more
Locations: City of Hope Nat'l Medical Center Duarte, California, United States

Univ. of California - Irvine Irvine, California, United States

UCLA Medical Center Los Angeles, California, United States

Sarah Cannon Research Institute Denver, Colorado, United States

View all 20 locations